The Latest Breaking News from FDA

The FDA just cleared 'Traumagel,' a wound-treating gel with 'the color and texture of hummus' that sounds like a real-life FPS medkit

Get Master Chief one of these, stat.

PC Gamer · Aug 19, 2024

The Future of Psychedelic Research Is In Limbo — Why the FDA’s Decision Changed Everything

The FDA just rejected MDMA-assisted therapy for PTSD. What's next for psychedelic drugs in science and everyday life?

Inverse · Aug 17, 2024

FDA Wants To Further Reduce Salt Levels In Packaged, Processed Food

After the successful execution of the Phase I target, the FDA plans to further reduce sodium levels by 20%, to bring the average intake to about 2,750 milligrams per day.

Medical Daily · Aug 16, 2024

Google Pixel Watch 3 vs. Samsung Galaxy Watch 7: which Android smartwatch should you buy?

Google Pixel Watch 3 vs. Samsung Galaxy Watch 7: Which Android smartwatch should you get? We have answers.

Tom’s Guide · Aug 15, 2024

A Single Episode Of Shingles Raises Cognitive Decline By 20%, Says Study

The pain and complications of shingles do not end with the episode, as a new study suggests that its impact could be long-term.

Medical Daily · Aug 15, 2024

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading.

StockNews.com · Aug 14, 2024

What is Neffy? FDA approves first nasal spray to treat severe allergies

Neffy, the first single-dose nasal spray approved to treat severe allergies, will hit the market in a matter of weeks

The Independent UK · Aug 14, 2024

Google Pixel Watch 3 is first smartwatch with pulse loss detection — here’s how it works

Google introduced a new pulse loss detection feature coming to the newly announced Pixel Watch 3 lineup.

Tom’s Guide · Aug 13, 2024

FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is the first such decision issued on a psychedelic drug application.

The Conversation · Aug 12, 2024

FDA approves 1st needle-free alternative to EpiPens

There's now an option to treat anaphylaxis via a nasal spray, rather than with an auto-injected medication.

LiveScience · Aug 12, 2024